Study Trichomonas Vaginalis: Understanding Trichomoniasis, Symptoms with clear, structured coverage of the key concepts in Parasitology. Kenya, Africa a...
Introduction Trichomonas vaginalis is a protozoan parasite responsible for trichomoniasis , a sexually transmitted infection (STI). It is unique among flagellates as it exists only in the trophozoite stage ; it does not form cysts. The organism primarily infects the urogenital tract of both males and females. Morphology Shape : Pear-shaped, with an undulating membrane. Size : 7–23 µm in length and 5–12 µm in width. Flagella : Five in total— four anterior and one posterior attached to the undulating membrane. Axostyle : Runs along the midline of the body and protrudes slightly at the posterior end. Nucleus : Single, oval-shaped, located anteriorly. Motility : Exhibits rapid, jerky movements in wet preparations. Life Cycle of Trichomonas vaginalis Only trophozoite stage is present; no cyst formation occurs. Mode of transmission : Sexual contact is the primary mode (vaginal, urethral, or anal intercourse). Transmission is facilitated by moist environments , including fomites (e.g., towels, contaminated medical instruments). Vertical transmission can occur during childbirth. Step-by-Step Life Cycle Infection occurs through sexual transmission → Trophozoites are introduced into the urogenital tract. Trophozoites multiply by binary fission and colonize the vagina, cervix, or male urethra and prostate . Survival in genital fluids → The trophozoites feed on host epithelial cells, leading to inflammation. Transmission to new host via direct sexual contact. Summary of the Life Cycle Trophozoite in urogenital tract → Binary fission (multiplication) → Colonization of urogenital tract → Transmission to new host via sexual contact Pathogenesis The parasite adheres to vaginal and urethral epithelium using its undulating membrane and flagella . Produces enzymes such as cystine proteases, lactic acid, and acetic acid , which cause: Disruption of normal vaginal flora (Lactobacilli) Reduction of vaginal pH Epithelial cell apoptosis and inflammatory response Causes petechial hemorrhages on the vaginal mucosa ("strawberry cervix"). Leads to vaginal epithelial desquamation , resulting in severe irritation. Clinical Features In Females Asymptomatic in 50% of cases Symptomatic cases present with : Frothy, yellow-green vaginal discharge (often foul-smelling) Vaginal itching and burning (pruritus) Dysuria (painful urination) Dyspareunia (pain during intercourse) Strawberry cervix (petechial hemorrhages on vaginal mucosa) In Males Mostly asymptomatic carriers Can cause: Urethritis (mild irritation or discharge) Prostatitis and epididymitis (rare complications) Complications In pregnant women , it increases the risk of: Preterm birth Low birth weight Neonatal pneumonia or conjunctivitis (if transmitted during birth) Increases susceptibility to other STIs , including HIV . Diagnosis of Trichomoniasis Microscopy (Wet Mount Preparation) – First-line Test Motile trophozoites with jerky movement seen under the microscope. Sensitivity : 50–70% (low in asymptomatic cases). Culture (Gold Standard Test) Diamond’s modified media or Trichomonas culture kit More sensitive than wet mount (~95%). Molecular Tests (PCR/Nucleic Acid Amplification Tests – NAATs) Most sensitive and specific method (~98%). Recommended for asymptomatic carriers . Serology (ELISA, Immunofluorescence Assays) Detects Trichomonas antigens in vaginal or urethral secretions. Less commonly used than PCR. Treatment of Trichomoniasis First-Line Treatment Metronidazole (Drug of Choice) Dosage : 2 g orally as a single dose OR 500 mg orally twice daily for 7 days Cure rate : 90% Tinidazole (Alternative to Metronidazole) Dosage : 2 g orally, single dose More effective and fewer side effects than metronidazole. Special Considerations Pregnant women : Metronidazole is safe in the second and third trimesters. Avoid high doses in the first trimester. Metronidazole-resistant cases :Increase dose to 2 g daily for 3–5 days Consider parenteral (IV) metronidazole if oral therapy fails. Treat sexual partners simultaneously to prevent reinfection. Prevention and Control Safe sexual practices : Use of condoms significantly reduces transmission. Avoidance of multiple sexual partners . Partner screening and treatment to prevent reinfection. Personal hygiene : Avoid sharing towels or undergarments. Proper sterilization of medical instruments to prevent fomite transmission. --- Key Points & Critical Notes Trichomonas vaginalis exists only in trophozoite form —no cyst stage. Sexually transmitted ; asymptomatic carriers (especially males) contribute to spread. Wet mount microscopy is the most common diagnostic method but has low sensitivity . PCR and culture are more accurate and recommended in asymptomatic individuals . Metronidazole and Tinidazole are the drugs of choice —treat both partners. Untreated infection increases susceptibility to HIV and adverse pregnancy outcomes. Strawberry cervix is a hallmark sign but is not present in all cases.